References
- Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol 2013; 38: 367-9. doi: 10.1111/ced.12016
- Heath MS, Bar A. Basal cell carcinoma. Dermatol Clin 2023; 41: 13-21. doi: 10.1016/j.det.2022.07.005
- Gordon R. Skin cancer: an overview of epidemiology and risk factors. Sem Oncol Nursing 2013; 29: 160-9. doi: 10.1016/j.soncn.2013.06.002
- Kim JYS, Kozlow JH, Mittal B, Kozlow JH, Mittal B, Moyer J, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78: 540-59. doi: 10.1016/j.jaad.2017.10.006
- Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, et al. Basal cell carcinoma. J Am Acad Dermatol 2019; 80: 321-39. doi: 10.1016/j.jaad.2018.02.083
- Peris K, Fargnoli MC, Kaufmann R, Arenberger P, Bastholt L, Seguin NB, et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma – update 2023. Eur J Cancer 2023; 192: 113254. doi: 10.1016/j.ejca.2023.113254
- Lyons P, Kennedy A, Clover AJP. Electrochemotherapy and basal cell carcinomas: first-time appraisal of the efficacy of electrochemotherapy on survivorship using FACE-Q. JPRAS Open 2021; 27: 119-28. doi: 10.1016/j.jpra.2020.12.004
- Russano F, Brugnolo D, Bisetto G, Del Fiore P, Rastrelli M, Mocellin S, et al. Electrochemotherapy treatment in a patient with an extended basal cell carcinoma of the face: a case report. JPM 2024; 14: 984. doi: 10.3390/jpm14090984
- Carpenè S, Silvestri B, Bertinazzi M, Armato E, Amadori M, Spinato R, et al. Electrochemotherapy as adjuvant treatment in a sinonasal mucosal melanoma in elderly patient: a case report. Eur Arch Otorhinolaryngol 2024; 281: 3853-8. doi: 10.1007/s00405-024-08606-z
- Sersa G, Mascherini M, Di Prata C, Odili J, de Terlizzi F, McKenzie GAG, et al. Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: a matched cohort analysis from the InspECT registry. Eur J Surg Oncol 2021; 47: 902-12. doi: 10.1016/j.ejso.2020.10.037
- Mir LM, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998; 77: 2336–42. doi: 10.1038/bjc.1998.388
- Clover AJP, Salwa SP, Bourke MG, McKiernan J, Forde PF, O’Sullivan ST, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; a randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol 2020; 46: 847-54. doi: 10.1016/j.ejso.2019.11.509
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejca.2020.06.020
- Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer 2016; 63: 41-52. doi: 10.1016/j.ejca.2016.05.001
- Bertino G, Muir T, Odili J, Groselj A, Marconato R, Curatolo P, et al; the InspECT BCC Working Group. Treatment of basal cell carcinoma with electrochemotherapy: insights from the InspECT Registry (2008–2019). Curr Oncol 2022; 29: 5324-37. doi: 10.3390/curroncol29080423
- Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 2008; 34: 232-40. doi: 10.1016/j.ejso.2007.05.016
- Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13. doi: 10.1016/j.ejcsup.2006.08.002
- Plaschke CC, Bertino G, McCaul JA, Grau JJ, de Bree R, Sersa G, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results from the treatment of mucosal cancers. Eur J Cancer 2017; 87: 172-81. doi: 10.1016/j.ejca.2017.10.008
- Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021: 47: 1836-46. doi: 10.1016/j.ejso.2021.03.229
- Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388-98. doi: 10.1038/sj.bjc.6604168
- Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729-46. doi: 10.1586/era.10.43
- Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25. doi: 10.1016/j.ejcsup.2006.08.003
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST Guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026
- Bertino G, Groselj A, Campana LG, Kunte C, Schepler H, Gehl J, et al. Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: the INSPECT experience (2008-2020). Front Oncol 2022; 12: 951662. doi: 10.3389/fonc.2022.951662
- Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensusbased interdisciplinary guidelines. Eur J Cancer 2019; 118: 10-34. doi: 10.1016/j.ejca.2019.06.003
- Strom TJ, Caudell JJ, Harrison LB. Management of BCC and SCC of the head and neck. Cancer Control 2016; 23: 220-7. doi: 10.1177/107327481602300305
- Justesen TF, Orhan A, Raskov H, Nolsoe C, Gögenur I. Electroporation and immunotherapy – unleashing the abscopal effect. Cancers 2022; 14: 2876. doi: 10.3390/cancers14122876
- Ferioli M, Perrone AM, De Iaco P, Zamfir AA, Ravegnini G, Buwenge M, et al. Clinical insights and future prospects: a comprehensive narrative review on immunomodulation induced by electrochemotherapy. Current Oncol 2024; 31: 6433-64. doi: 10.3390/curroncol31100478
- Jayaraman SS, Rayhan DJ, Hazany S, Kolodney MS. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol 2014; 134: 213-20. doi: 10.1038/jid.2013.276
- Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, et al. Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy. Basic Clin Pharmacol Toxicol 2018; 123: 247-56. doi: 10.1111/bcpt.13012
- Jamsek C, Sersa G, Bosnjak M, Groselj A. Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer. Radiol Oncol 2020; 54: 79-85. doi: 10.2478/raon-2020-0009
- Andersen YMF, Karmisholt K, Høgsberg T, Nielsen ML, Brosbøl A, Stave S, et al. 10 years of Mohs micrographic surgery in Denmark: results from a nationwide cohort. Acta Derm Venereol 2025; 105: adv41118. doi: 10.2340/actadv.v105.41118